| Literature DB >> 25213690 |
Hao-Kuang Wang, Chao-Ming Hung, Sheng-Hsiang Lin, Yi-Cheng Tai, Kang Lu, Po-Chou Liliang, Chi-Wei Lin, Yi-Che Lee, Pei-Hsuan Fang, Li-Ching Chang, Ying-Chun Li.
Abstract
BACKGROUND: Dementia has been associated with an increased risk of hip fracture. However, little research has been conducted on the impact of dementia on wrist or vertebral fracture development. The aim of this study was to investigate whether dementia is a risk factor for different types of fracture in Taiwan.Entities:
Mesh:
Year: 2014 PMID: 25213690 PMCID: PMC4172891 DOI: 10.1186/s12883-014-0175-2
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Figure 1Flow chart of the study population.
Comparison of demographic characteristics and comorbidities between patients with and without dementia
|
|
| ||||
|---|---|---|---|---|---|
|
|
| ||||
|
|
|
|
|
|
|
| Sex | 1.000 | ||||
| Male | 671 | 47.66 | 3355 | 47.66 | |
| Female | 737 | 52.34 | 3685 | 52.34 | |
| Age, mean ± SD | 76.38 ± 7.45 | 76.38 ± 7.45 | 1.000 | ||
| Age | 1.000 | ||||
| 60-74 | 270 | 19.18 | 1350 | 19.18 | |
| ≥ 75 | 1138 | 80.82 | 5690 | 80.82 | |
| Geographic region | 0.4799 | ||||
| Northern | 600 | 42.61 | 3017 | 42.86 | |
| Central | 348 | 24.72 | 1795 | 25.50 | |
| Southern | 398 | 28.27 | 1859 | 26.41 | |
| Eastern | 39 | 2.77 | 238 | 3.38 | |
| Missing | 23 | 1.63 | 131 | 1.86 | |
| Comorbidities | |||||
| Diabetes | 263 | 18.68 | 119 | 1.69 | <.0001 |
| Dyslipidemia | 193 | 13.71 | 94 | 1.34 | <.0001 |
| Hypertension | 718 | 50.99 | 447 | 6.35 | <.0001 |
| Coronary heart disease | 305 | 21.66 | 198 | 2.81 | <.0001 |
| Heart failure | 65 | 4.62 | 52 | 0.74 | <.0001 |
| Atrial fibrillation | 19 | 1.35 | 17 | 0.24 | <.0001 |
| Peripheral vascular disease | 57 | 4.05 | 35 | 0.50 | <.0001 |
| Cerebrovascular disease | 269 | 19.11 | 104 | 1.48 | <.0001 |
| Respiratory disease | 238 | 16.90 | 148 | 2.10 | <.0001 |
| Peptic ulcer disease | 252 | 17.90 | 162 | 2.30 | <.0001 |
| Chronic liver disease | 141 | 10.01 | 66 | 0.94 | <.0001 |
| Chronic kidney disease | 95 | 6.75 | 42 | 0.60 | <.0001 |
| Rheumatologic disease | 43 | 3.05 | 20 | 0.28 | <.0001 |
| Cancer | 46 | 3.27 | 43 | 0.61 | <.0001 |
SD, standard deviation.
Fracture risk among sampled patients during the 3-year follow-up period from index health care utilization (N = 8,448)
|
|
|
|
| |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
| Total | 264 | 18.75 | 38 | 20.77 | 226 | 18.45 | 1098 | 15.60 |
| Crude HR (95% CI) | 1.37* (1.19- 1.57) | 1.40* (1.18-1.61) | 1.36* (1.13-1.67) | 1.00 | ||||
| Adjusted HR (95% CI) | 1.34* (1.14- 1.58) | 1.37* (1.13-1.59) | 1.33* (1.11-1.63) | 1.00 | ||||
| Hip fracture | 109 | 7.74 | 17 | 9.29 | 92 | 7.51 | 306 | 4.35 |
| Crude HR (95% CI) | 2.03* (1.63- 2.52) | 2.31* (1.57- 2.76) | 2.01* (1.49- 2.93) | 1.00 | ||||
| Adjusted HR (95% CI) | 1.92* (1.48- 2.49) | 2.19* (1.43- 2.88) | 1.87* (1.33- 2.83) | 1.00 | ||||
| Wrist fracture | 47 | 3.34 | 7 | 3.83 | 40 | 3.27 | 177 | 2.51 |
| Crude HR (95% CI) | 1.43 (0.92- 2.04) | 1.55 (0.95- 2.61) | 1.16 (0.88- 2.74) | 1.00 | ||||
| Adjusted HR (95% CI) | 1.66 (0.97- 2.55) | 1.49 (0.98- 2.57) | 1.34 (0.91- 2.88) | 1.00 | ||||
| Vertebral fracture | 93 | 6.61 | 14 | 7.65 | 79 | 6.45 | 548 | 7.78 |
| Crude HR (95% CI) | 0.99 (0.79- 1.23) | 1.00 (0.83- 1.31) | 0.91 (0.72- 1.78) | 1.00 | ||||
| Adjusted HR (95% CI) | 0.88 (0.67- 1.14) | 0.92 (0.69- 1.22) | 0.88 (0.62- 1.53) | 1.00 | ||||
*P < 0.05. HR, hazard ratio; CI, confidence interval. Hazard ratios were calculated with the stratified Cox proportional regression method (stratified by sex, age group, and the year of index health care use) during the 3-year follow-up period. Adjustments were made for Charlson Comorbidity Index in the patients.
Fracture risk among patients with osteoporosis during the 3-year follow-up period from index health care utilization
|
|
| |||
|---|---|---|---|---|
|
|
|
|
|
|
| Total | ||||
| Osteoporosis | 87 | 24.93 | 330 | 22.04 |
| Crude HR (95% CI) | 1.33 (1.04- 1.69)* | 1.00 | ||
| Adjusted HR (95% CI) | 1.32 (0.98- 1.78) | 1.00 | ||
| Hip fracture | ||||
| Osteoporosis | 25 | 7.16 | 64 | 4.28 |
| Crude HR (95% CI) | 1.98 (1.24- 3.15)* | 1.00 | ||
| Adjusted HR (95% CI) | 2.27 (1.28- 4.01)* | 1.00 | ||
| Wrist fracture | ||||
| Osteoporosis | 13 | 3.72 | 34 | 2.27 |
| Crude HR (95% CI) | 1.85 (0.92- 3.70) | 1.00 | ||
| Adjusted HR (95% CI) | 2.39 (0.98- 5.80) | 1.00 | ||
| Vertebral fracture | ||||
| Osteoporosis | 45 | 12.89 | 213 | 14.23 |
| Crude HR (95% CI) | 1.07 (0.78- 1.48) | 1.00 | ||
| Adjusted HR (95% CI) | 0.87 (0.58- 1.30) | 1.00 | ||
*P < 0.05. HR, hazard ratio; CI, confidence interval. Hazard ratios were calculated with the stratified Cox proportional regression method (stratified by sex, age group, and the year of index health care use) during the 3-year follow-up period. Adjustments were made for Charlson Comorbidity Index in the patients.
Fracture risk among patients without osteoporosis during the 3-year follow-up period from index health care utilization
|
|
| |||
|---|---|---|---|---|
|
|
|
|
|
|
| Total | ||||
| Non-osteoporosis | 177 | 16.71 | 768 | 13.86 |
| Crude HR (95% CI) | 1.36 (1.15- 1.60)* | 1.00 | ||
| Adjusted HR (95% CI) | 1.35 (1.11- 1.64)* | 1.00 | ||
| Hip fracture | ||||
| Non-osteoporosis | 84 | 7.93 | 242 | 4.37 |
| Crude HR (95% CI) | 2.04 (1.59- 2.62)* | 1.00 | ||
| Adjusted HR (95% CI) | 1.84 (1.37- 2.46)* | 1.00 | ||
| Wrist fracture | ||||
| Non-osteoporosis | 34 | 3.21 | 142 | 2.56 |
| Crude HR (95% CI) | 1.32 (0.87- 1.99) | 1.00 | ||
| Adjusted HR (95% CI) | 1.48 (0.93- 2.43) | 1.00 | ||
| Vertebral fracture | ||||
| Non-osteoporosis | 48 | 4.53 | 335 | 6.04 |
| Crude HR (95% CI) | 0.86 (0.64- 1.17) | 1.00 | ||
| Adjusted HR (95% CI) | 0.88 (0.62- 1.25) | 1.00 | ||
*P < 0.05. HR, hazard ratio; CI, confidence interval. Hazard ratios were calculated with the stratified Cox proportional regression method (stratified by sex, age group, and the year of index health care use) during the 3-year follow-up period. Adjustments were made for Charlson Comorbidity Index in the patients.